Showing results (31-40 of 169) with videos related to
Sort By:
Pageof 17
Current Hypertension Reports|April 6, 2011
Mineralocorticoid receptor blockade in chronic kidney diseaseMatthew J Volk, Andrew S Bomback, Philip J KlemmerKidney International|June 18, 2016
Phosphate enemas and GFR decline: it's premature to sound the alarmGlen S Markowitz, Andrew S Bomback, Mark A PerazellaDiscovery Medicine|October 28, 2011
Treating lupus in the kidney: where are we now, and where are we going?Pietro A A Canetta, Andrew S Bomback, Jai RadhakrishnanClinical Journal of the American Society of Nephrology : CJASN|February 6, 2016
American Society of Nephrology Quiz and Questionnaire 2015: Glomerular DiseasesAndrew S Bomback, Mark A Perazella, Michael J ChoiKidney International Reports|November 17, 2017
Complement-Mediated Glomerular Diseases: A Tale of 3 PathwaysAndrew S Bomback, Glen S Markowitz, Gerald B AppelAdvances in Chronic Kidney Disease|March 28, 2012
Renal biopsy in the elderly and very elderly: useful or not?Andrew S Bomback, Leal C Herlitz, Glen S MarkowitzClinical Nephrology|December 6, 2012
Aldosterone blockade as an alternative renin-angiotensin-aldosterone system blocking agent in cases of treatment associated anemiaRupali S Avasare, Gerald B Appel, Andrew S BombackClinical Journal of the American Society of Nephrology : CJASN|February 11, 2015
American Society of Nephrology quiz and questionnaire 2014: glomerular diseasesAndrew S Bomback, Mark A Perazella, Michael J ChoiAdvances in Chronic Kidney Disease|February 24, 2015
Aldosterone blockade in CKD: emphasis on pharmacologyMichael H Schwenk, Jamie S Hirsch, Andrew S BombackClinical Journal of the American Society of Nephrology : CJASN|April 12, 2015
Drug-induced glomerular disease: direct cellular injuryGlen S Markowitz, Andrew S Bomback, Mark A PerazellaPageof 17